English | Hindi | Spanish | Deutch
+91-11-23370009hsg@ima-india.org

IMA-PvPI


Minutes of Meeting

Title:Meeting regarding cooperation between Indian Pharmacopoeia Commission (IPC), National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) and Indian Medical Association (IMA) to promote the patient safety in the country

 Date:6th January 2016  Time: 3.30 pm onwards

Venue:O/o DCG(I),Central Drugs Standard Control Organization (CDSCO), FDA Bhawan, New Delhi.

Attendance:

S.No.

Name

Designation

  1.  

Dr. G. N. Singh

Drugs Controller General (India)&

Secretary-cum-Scientific Director, IPC

2. 

Dr. S. S. Agarwal

President, IMA

  1.  

Dr. K. K. Agarwal

Honorary Secretary General, IMA

4. 

Dr. Ramesh Datta

Joint Secretary, IMA

5. 

Dr. R. N. Tandon

Honorary Finance Secretary, IMA

6. 

Dr. Manjul Mehta

Assistant Secretary, IMA

7

Dr. V. K. Monga

Dean of Studies-Elect, IMA CGP

8

Ms. A. Visala

Deputy Drugs Controller (I), CDSCO Hq

9

Dr. Mita Nandy

Consultant, CDSCO

10

Dr. Kalaiselvan

Principal Scientific Officer, IPC

11

Dr. Prasad Thota

Scientific Assistant, IPC

12

Sh. Varun Chopra

Technical Associate, IPC

Background

A meeting regarding cooperation between Indian Pharmacopoeia Commission (IPC), National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) and Indian Medical Association (IMA) to promote the patient safety in the country was held on 6th January 2016 at CDSCO Hq, FDA Bhawan, New Delhi.

IPC, NCC-PvPI and Indian Medical Association (IMA) mutually agreed to work together to promote the patient safety in the country.

Letter of Intent for Cooperation

A Letter of Intent for cooperation was signed between IPC, NCC-PvPI and IMA on 6th January 2016. Dr. G. N. Singh, DCG(I) &Secretary-cum-Scientific Director, IPC and Dr. S. S. Agarwal, President, IMA signed the Letter of Intent for cooperation on behalf of IPC and IMA respectively and exchanged the same.

Expected Outcome

NCC-PvPI and IMA agreed to cooperate for the following areas:

  1. PvPI-IMA patient safety monitoring cell to be started at IMA Head Quarter in the designated space provided by IMA.
  2. Organising Continuing Medical Educations (CMEs), disseminating PvPI information/concept of Pharmacovigilance (PV) in IMA in News, Journals etc.
  3. IMA to identify the nodal centres for education/ advocacy and ADR monitoring and recommend to NCC-PvPI for recognition.
  4. Training to the nodal coordinators/medical officers.
  5. Development/up-gradation of Mobile app. for ADR monitoring.
  6. A “National Day on Patient Safety” is to be celebrated by NCC-PvPI and IMA in collaboration.
  7. Other areas to promote patient safety.

              

Dr. G. N. Singh, DCG(I) & Secretary-cum-Scientific Director, IPC (Right) and Dr. S. S. Agarwal, President, IMA (Left) signing and exchanging the Letter of Intent.